AAPS Foundation to Promote Drug Development - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AAPS Foundation to Promote Drug Development



Untitled Document

AAPS announced the launch of the AAPS Foundation, an information network for pharmaceutical scientists around the world. The foundation will help advance the contributions of the pharmaceutical sciences to global health.

The AAPS Foundation will support scientists and initiatives that promote the discovery, development, and manufacture of drugs by attracting and providing resources used to advance research, education, and training. The foundation hopes to assist current pharmaceutical scientists, in addition to expanding and engaging the interests of future generations of scientists.

AAPS Foundation funding priorities will include graduate student fellowships, through AAPS’ strategic partnership with the American Foundation for Pharmaceutical Educations, leaders with a 70-year history in graduate education; Undergraduate Research Grants, in outstanding academic laboratories, to encourage those investigating a research career; multiyear new investigator grants to the most promising young faculty members; a Leadership Institute to ensure that current students and research professionals will thrive in the pharmaceutical industry, academia, or government; and a Teach the Teacher program, developed to increase outreach to K-12 students and also establish ongoing relationships with high school science and math teachers around the country and globe.

Source: AAPS

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here